Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
4.930
+0.020 (0.41%)
Oct 21, 2025, 10:45 AM CST
SHA:600998 Revenue
Jointown Pharmaceutical Group had revenue of 39.09 billion CNY in the quarter ending June 30, 2025, with 6.52% growth. This brings the company's revenue in the last twelve months to 155.75 billion, up 5.27% year-over-year. In the year 2024, Jointown Pharmaceutical Group had annual revenue of 151.81 billion with 1.11% growth.
Revenue (ttm)
155.75B
Revenue Growth
+5.27%
P/S Ratio
0.16
Revenue / Employee
5.16M
Employees
30,169
Market Cap
24.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 151.81B | 1.67B | 1.11% |
Dec 31, 2023 | 150.14B | 9.72B | 6.92% |
Dec 31, 2022 | 140.42B | 18.02B | 14.72% |
Dec 31, 2021 | 122.41B | 11.55B | 10.42% |
Dec 31, 2020 | 110.86B | 11.36B | 11.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |